Cardiovascular Disease in the Rheumatic Diseases: How Systemic Inflammation May Contribute to Atherogenesis
Journal:
Current Rheumatology Reviews
Volume:
2
Page:
279-288
Author(s):
Kathleen Maksimowicz-McKinnon
Antibiotics in the Treatment of Reactive Arthritis
Journal:
Current Rheumatology Reviews
Volume:
2
Page:
303-308
Author(s):
Auli Toivanen, Timo Yli-Kerttula and Timo Mottonen
Anti-TNF-α Antibody Therapies in Autoimmune Diseases
Journal:
Current Topics in Medicinal Chemistry
Volume:
6
Page:
1707-1714
Author(s):
Kokona Chatzantoni and Athanasia Mouzaki
Novel Targets for Antiinflammatory and Antiarthritic Agents
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
2437-2454
Author(s):
R. G. Kulkarni, G. Achaiah and G. Narahari Sastry
Antagonists of CCR4 as Immunomodulatory Agents
Journal:
Current Topics in Medicinal Chemistry
Volume:
6
Page:
1335-1344
Author(s):
Ashok V. Purandare and John E. Somerville
Pharmacogenetics, Target Molecules, and Biological Anti-Rheumatic Drugs in Autoimmune/Chronic Inflammatory Rheumatic Diseases
Journal:
Current Pharmacogenomics
Volume:
4
Page:
105-111
Author(s):
G. Ferraccioli, B. Tolusso and M. De Santis
Gastrointestinal Involvement in Children and Adolescents with Rheumatic Diseases
Journal:
Current Rheumatology Reviews
Volume:
2
Page:
207-213
Author(s):
Peter Weber, Bolz Dieter and Klaus-Peter Zimmer
Pathogenesis and Biomarkers in Spondyloarthritis: Clues from Microarray Analyses
Journal:
Current Rheumatology Reviews
Volume:
2
Page:
215-218
Author(s):
David T. Y. Yu
Ankylosing Spondylitis, HLA-B27 and Klebsiella - An Overview: Proposal for Early Diagnosis and Treatment
Journal:
Current Rheumatology Reviews
Volume:
2
Page:
55-68
Author(s):
Alan Ebringer, Taha Rashid, Clyde Wilson, Teresa Ptaszynska and Mark Fielder
Use of Anti-Infective Drugs in Rheumatology
Journal:
Anti-Infective Agents in Medicinal Chemistry
Volume:
5
Page:
55-61
Author(s):
Jacob N. Ablin